BCA
CVS icon

Bay Colony Advisors’s CVS Health CVS Stock Holding History

Bay Colony Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464K Sell
4,486
-112
-2% -$10K 0.05% 279
2026
Q1 		$330K Sell
4,598
-62
-1% -$4.78K 0.04% 363
2025
Q4 		$370K Sell
4,660
-129
-3% -$10.2K 0.04% 341
2025
Q3 		$361K Sell
4,789
-264
-5% -$18.1K 0.04% 349
2025
Q2 		$349K Buy
5,053
+52
+1% +$3.41K 0.05% 315
2025
Q1 		$336K Buy
5,001
+134
+3% +$8.02K 0.05% 309
2024
Q4 		$219K Sell
4,867
-260
-5% -$14.6K 0.03% 406
2024
Q3 		$322K Sell
5,127
-540
-10% -$31.5K 0.05% 306
2024
Q2 		$335K Sell
5,667
-761
-12% -$47.6K 0.06% 276
2024
Q1 		$513K Buy
6,428
+201
+3% +$15.4K 0.09% 205
2023
Q4 		$492K Buy
6,227
+110
+2% +$7.83K 0.1% 194
2023
Q3 		$427K Buy
6,117
+279
+5% +$19.8K 0.1% 191
2023
Q2 		$404K Buy
5,838
+19
+0.3% +$1.35K 0.1% 189
2023
Q1 		$435K Sell
5,819
-2,138
-27% -$179K 0.11% 179
2022
Q4 		$742K Buy
7,957
+23
+0.3% +$2.22K 0.2% 124
2022
Q3 		$757K Buy
7,934
+171
+2% +$16.9K 0.22% 106
2022
Q2 		$743K Sell
7,763
-8,239
-51% -$804K 0.19% 124
2022
Q1 		$1.62M Sell
16,002
-3,732
-19% -$392K 0.39% 65
2021
Q4 		$2.04M Buy
19,734
+503
+3% +$46.5K 0.58% 44
2021
Q3 		$1.63M Sell
19,231
-392
-2% -$32.8K 0.53% 51
2021
Q2 		$1.64M Buy
19,623
+1,024
+6% +$83.9K 0.55% 46
2021
Q1 		$1.4M Buy
18,599
+5,853
+46% +$426K 0.54% 52
2020
Q4 		$871K Sell
12,746
-1,427
-10% -$92.8K 0.46% 68
2020
Q3 		$828K Buy
14,173
+1,202
+9% +$74.8K 0.51% 66
2020
Q2 		$843K Buy
12,971
+1,138
+10% +$71.7K 0.61% 54
2020
Q1 		$702K Buy
11,833
+2,363
+25% +$158K 0.64% 51
2019
Q4 		$701K Buy
9,470
+785
+9% +$55.1K 0.46% 73
2019
Q3 		$548K Buy
+8,685
New +$515K 0.37% 93
2018
Q3 		– Sell
-1,323
Closed -$85K – 340
2018
Q2 		$85K Buy
+1,323
New +$87.2K 0.06% 280

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bay Colony Advisors's CVS Position: Q2 2026 in Review

Bay Colony Advisors reduced its CVS Health (CVS) stake by 2.4% in Q2 2026, selling an estimated $10K and leaving 4,486 shares worth $464K. The position accounts for 0.05% of the portfolio, ranked #279.

Bay Colony Advisors first reported a position in CVS in Q2 2018 and has held it in 29 quarters since. The position peaked at $2.04M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Bay Colony Advisors held 4,486 shares of CVS Health worth $464K as of Q2 2026.
  • Bay Colony Advisors sold 112 CVS Health shares in Q2 2026, an estimated $10K.
  • CVS Health made up 0.05% of Bay Colony Advisors's portfolio in Q2 2026, its #279 holding.
  • Bay Colony Advisors first reported a position in CVS Health in Q2 2018 and has held it in 29 quarters since.
  • Bay Colony Advisors's CVS Health position peaked at $2.04M in Q4 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.